CN110447799A - A kind of complex solid plant beverage and preparation method thereof for improving intestinal flora - Google Patents
A kind of complex solid plant beverage and preparation method thereof for improving intestinal flora Download PDFInfo
- Publication number
- CN110447799A CN110447799A CN201810432982.XA CN201810432982A CN110447799A CN 110447799 A CN110447799 A CN 110447799A CN 201810432982 A CN201810432982 A CN 201810432982A CN 110447799 A CN110447799 A CN 110447799A
- Authority
- CN
- China
- Prior art keywords
- powder
- parts
- raspberry
- glycan
- solid beverage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 57
- 239000007787 solid Substances 0.000 title claims abstract description 57
- 230000000968 intestinal effect Effects 0.000 title claims abstract description 49
- 238000002360 preparation method Methods 0.000 title claims abstract description 30
- 239000000843 powder Substances 0.000 claims abstract description 327
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 128
- 235000011034 Rubus glaucus Nutrition 0.000 claims abstract description 109
- 235000009122 Rubus idaeus Nutrition 0.000 claims abstract description 109
- 240000007651 Rubus glaucus Species 0.000 claims abstract description 106
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 106
- 241000894006 Bacteria Species 0.000 claims abstract description 71
- 239000004310 lactic acid Substances 0.000 claims abstract description 64
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 64
- 150000001875 compounds Chemical class 0.000 claims abstract description 61
- 235000006481 Colocasia esculenta Nutrition 0.000 claims abstract description 43
- 244000205754 Colocasia esculenta Species 0.000 claims abstract description 43
- 235000001466 Ribes nigrum Nutrition 0.000 claims abstract description 34
- 235000016954 Ribes hudsonianum Nutrition 0.000 claims abstract description 33
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims abstract description 33
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 claims abstract description 33
- 235000016623 Fragaria vesca Nutrition 0.000 claims abstract description 32
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims abstract description 32
- 240000001890 Ribes hudsonianum Species 0.000 claims abstract description 32
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims abstract description 31
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 claims abstract description 31
- 235000021014 blueberries Nutrition 0.000 claims abstract description 31
- 235000004634 cranberry Nutrition 0.000 claims abstract description 31
- 240000009088 Fragaria x ananassa Species 0.000 claims abstract description 30
- 235000017524 noni Nutrition 0.000 claims abstract description 28
- 244000131360 Morinda citrifolia Species 0.000 claims abstract description 27
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims abstract description 25
- 239000000845 maltitol Substances 0.000 claims abstract description 24
- 235000010449 maltitol Nutrition 0.000 claims abstract description 24
- 229940035436 maltitol Drugs 0.000 claims abstract description 24
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 23
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000000811 xylitol Substances 0.000 claims abstract description 22
- 235000010447 xylitol Nutrition 0.000 claims abstract description 22
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 22
- 229960002675 xylitol Drugs 0.000 claims abstract description 22
- 238000013329 compounding Methods 0.000 claims abstract description 15
- 240000000851 Vaccinium corymbosum Species 0.000 claims abstract 5
- 150000004676 glycans Chemical class 0.000 claims description 66
- 244000291414 Vaccinium oxycoccus Species 0.000 claims description 32
- 235000021028 berry Nutrition 0.000 claims description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 230000018044 dehydration Effects 0.000 claims description 23
- 238000006297 dehydration reaction Methods 0.000 claims description 23
- 241000186000 Bifidobacterium Species 0.000 claims description 20
- 239000002994 raw material Substances 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 18
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 16
- 238000001035 drying Methods 0.000 claims description 16
- 239000011812 mixed powder Substances 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 12
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims description 10
- 229940009289 bifidobacterium lactis Drugs 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- 230000032683 aging Effects 0.000 claims description 8
- 238000004140 cleaning Methods 0.000 claims description 8
- 229910052757 nitrogen Inorganic materials 0.000 claims description 8
- 238000005520 cutting process Methods 0.000 claims description 7
- 238000007710 freezing Methods 0.000 claims description 7
- 230000008014 freezing Effects 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 7
- 238000005507 spraying Methods 0.000 claims description 7
- 244000116699 Lactobacillus acidophilus NCFM Species 0.000 claims description 4
- 235000009195 Lactobacillus acidophilus NCFM Nutrition 0.000 claims description 4
- 244000235659 Rubus idaeus Species 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 2
- 150000005846 sugar alcohols Chemical class 0.000 claims description 2
- 239000002023 wood Substances 0.000 claims description 2
- 230000009286 beneficial effect Effects 0.000 abstract description 5
- 238000009395 breeding Methods 0.000 abstract description 5
- 230000001488 breeding effect Effects 0.000 abstract description 5
- 230000007774 longterm Effects 0.000 abstract description 5
- 240000001717 Vaccinium macrocarpon Species 0.000 abstract 1
- 239000012467 final product Substances 0.000 abstract 1
- 244000077233 Vaccinium uliginosum Species 0.000 description 27
- 241000282414 Homo sapiens Species 0.000 description 21
- 239000003814 drug Substances 0.000 description 15
- 239000001963 growth medium Substances 0.000 description 15
- 210000000936 intestine Anatomy 0.000 description 14
- 230000000694 effects Effects 0.000 description 13
- 235000013339 cereals Nutrition 0.000 description 12
- 229940079593 drug Drugs 0.000 description 12
- 239000000203 mixture Substances 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 239000000284 extract Substances 0.000 description 10
- 230000036541 health Effects 0.000 description 10
- 239000004615 ingredient Substances 0.000 description 10
- 239000000463 material Substances 0.000 description 10
- 241000193830 Bacillus <bacterium> Species 0.000 description 9
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 9
- 229930006000 Sucrose Natural products 0.000 description 9
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 9
- 235000019441 ethanol Nutrition 0.000 description 9
- 206010010774 Constipation Diseases 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- 235000016709 nutrition Nutrition 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 239000005720 sucrose Substances 0.000 description 8
- 239000003205 fragrance Substances 0.000 description 7
- 230000006870 function Effects 0.000 description 6
- 239000002304 perfume Substances 0.000 description 6
- 238000005303 weighing Methods 0.000 description 6
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 description 5
- 240000001046 Lactobacillus acidophilus Species 0.000 description 5
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- 235000009754 Vitis X bourquina Nutrition 0.000 description 5
- 235000012333 Vitis X labruscana Nutrition 0.000 description 5
- 240000006365 Vitis vinifera Species 0.000 description 5
- 235000014787 Vitis vinifera Nutrition 0.000 description 5
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 5
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 238000011049 filling Methods 0.000 description 5
- 244000005709 gut microbiome Species 0.000 description 5
- 229910052742 iron Inorganic materials 0.000 description 5
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 5
- 229940118199 levulan Drugs 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000003765 sweetening agent Substances 0.000 description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- 241000193468 Clostridium perfringens Species 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 241000305071 Enterobacterales Species 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 235000001465 calcium Nutrition 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 230000035622 drinking Effects 0.000 description 4
- 235000003599 food sweetener Nutrition 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 229960003284 iron Drugs 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 230000008855 peristalsis Effects 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 241000194033 Enterococcus Species 0.000 description 3
- 101710146739 Enterotoxin Proteins 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 3
- 235000011430 Malus pumila Nutrition 0.000 description 3
- 235000015103 Malus silvestris Nutrition 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 244000052616 bacterial pathogen Species 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- -1 corncob Substances 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 235000013325 dietary fiber Nutrition 0.000 description 3
- 239000000147 enterotoxin Substances 0.000 description 3
- 231100000655 enterotoxin Toxicity 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 230000000050 nutritive effect Effects 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 239000006041 probiotic Substances 0.000 description 3
- 235000018291 probiotics Nutrition 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 3
- 229960003495 thiamine Drugs 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 241000609240 Ambelania acida Species 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 244000307700 Fragaria vesca Species 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 240000004343 Indigofera suffruticosa Species 0.000 description 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 241001312569 Ribes nigrum Species 0.000 description 2
- 241001412171 Rubus corchorifolius Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 240000000111 Saccharum officinarum Species 0.000 description 2
- 235000007201 Saccharum officinarum Nutrition 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 244000078534 Vaccinium myrtillus Species 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 235000010208 anthocyanin Nutrition 0.000 description 2
- 239000004410 anthocyanin Substances 0.000 description 2
- 229930002877 anthocyanin Natural products 0.000 description 2
- 150000004636 anthocyanins Chemical class 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000000675 anti-caries Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 239000010905 bagasse Substances 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000001013 cariogenic effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000021022 fresh fruits Nutrition 0.000 description 2
- 229960002737 fructose Drugs 0.000 description 2
- 230000003862 health status Effects 0.000 description 2
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 229910052603 melanterite Inorganic materials 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- XKLJHFLUAHKGGU-UHFFFAOYSA-N nitrous amide Chemical compound ON=N XKLJHFLUAHKGGU-UHFFFAOYSA-N 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000009711 regulatory function Effects 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- GDSOZVZXVXTJMI-SNAWJCMRSA-N (e)-1-methylbut-1-ene-1,2,4-tricarboxylic acid Chemical compound OC(=O)C(/C)=C(C(O)=O)\CCC(O)=O GDSOZVZXVXTJMI-SNAWJCMRSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- JHGWQSGWUPCKNT-UHFFFAOYSA-N 2-tert-butyl-4-methyl-1,3,5-trinitrobenzene Chemical compound CC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C(C(C)(C)C)=C1[N+]([O-])=O JHGWQSGWUPCKNT-UHFFFAOYSA-N 0.000 description 1
- 208000004611 Abdominal Obesity Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 208000007743 Acute Abdomen Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 240000004510 Agastache rugosa Species 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241001254604 Angelica pubescens Species 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 235000009109 Betula pendula Nutrition 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 206010065941 Central obesity Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 229910021580 Cobalt(II) chloride Inorganic materials 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 241000588921 Enterobacteriaceae Species 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 241000726221 Gemma Species 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 240000008669 Hedera helix Species 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 108010034145 Helminth Proteins Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- 241000167847 Koelreuteria paniculata Species 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 241001147746 Lactobacillus delbrueckii subsp. lactis Species 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 241000157491 Morinda Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- FLDFNEBHEXLZRX-DLQNOBSRSA-N Nystose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(O[C@@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FLDFNEBHEXLZRX-DLQNOBSRSA-N 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 241000606860 Pasteurella Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- 235000001537 Ribes X gardonianum Nutrition 0.000 description 1
- 235000001535 Ribes X utile Nutrition 0.000 description 1
- 235000016919 Ribes petraeum Nutrition 0.000 description 1
- 244000281247 Ribes rubrum Species 0.000 description 1
- 235000002355 Ribes spicatum Nutrition 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241001050737 Sambucus williamsii Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 241000988588 Torricellia Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 235000011720 Vaccinium uliginosum Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000012805 animal sample Substances 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 150000001453 anthocyanidins Chemical class 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 239000010692 aromatic oil Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000006567 cellular energy metabolism Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229910052927 chalcanthite Inorganic materials 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-M cholate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-M 0.000 description 1
- 229940099352 cholate Drugs 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 229920002770 condensed tannin Polymers 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000010410 dusting Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229910052564 epsomite Inorganic materials 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 150000007946 flavonol Chemical class 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 229940084434 fungoid Drugs 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 244000000013 helminth Species 0.000 description 1
- 108010037896 heparin-binding hemagglutinin Proteins 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000005027 intestinal barrier Anatomy 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 230000004673 intestinal mucosal barrier function Effects 0.000 description 1
- 208000002551 irritable bowel syndrome Diseases 0.000 description 1
- 150000002584 ketoses Chemical class 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 208000010553 multiple abscesses Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 235000020729 noni extract Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- FLDFNEBHEXLZRX-UHFFFAOYSA-N nystose Natural products OC1C(O)C(CO)OC1(CO)OCC1(OCC2(OC3C(C(O)C(O)C(CO)O3)O)C(C(O)C(CO)O2)O)C(O)C(O)C(CO)O1 FLDFNEBHEXLZRX-UHFFFAOYSA-N 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000008601 oleoresin Substances 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 229940012843 omega-3 fatty acid Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 230000024241 parasitism Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 235000011649 selenium Nutrition 0.000 description 1
- 229940091258 selenium supplement Drugs 0.000 description 1
- 235000021391 short chain fatty acids Nutrition 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 235000021092 sugar substitutes Nutrition 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000031068 symbiosis, encompassing mutualism through parasitism Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 208000000143 urethritis Diseases 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000000304 virulence factor Substances 0.000 description 1
- 230000007923 virulence factor Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 240000004494 yellow birch Species 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/531—Lactis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a kind of compound solid beverage and preparation method thereof for improving intestinal flora, and compound solid beverage includes 200-800 parts of oligofructose, lactic acid bacteria compounding powder 100-500 parts, 80-520 parts of maltitol, 80-520 parts of xylitol, 66-264 parts of taro powder, 40-160 parts of raspberry powder, 40-160 parts of blackcurrant powder, 40-160 parts of strawberry powder, 4-16 parts of synthetism rasp berry fruit powder, 8-32 parts of A Sayi fruit powder, 12-48 parts of Noni fruit powder, 8-32 parts of Cranberry powder, 8-32 parts of blueberry powder.Preparation method is to mix each component to obtain the final product, and compound solid beverage provided by the invention can not only improve the breeding of beneficial bacterium in enteron aisle, and long-term consumption will not influence other normal floras.
Description
Technical field
The present invention relates to technical field of health care more particularly to a kind of for improving the complex solid plant of intestinal flora
Beverage and preparation method thereof.
Background technique
Probiotics, which refers to, plays beneficial effect by improving the host intestine flora ecological balance after use, reaches and improves place
The active bacteria formulation and its metabolite of main (humans and animals) general level of the health and health status.Idicatio includes: neutral or acute abdomen
It rushes down, indigestion, abdominal distension and intestinal bacilli illness etc..In actual clinical application, probiotics is also comprehensive frequently as intestines easily swash
The adjuvant treatment of simulator sickness and inflammatory bowel disease.
From the point of view of current medical evidence, it is comprehensive to improve intestines easily swash for the remission rate of raising irritable bowel syndrome for probiotics
The quality of life curative effect for patients with inflammatory bowel disease of seeking peace is clear, but the drug or functionality for improving enterobacteriaceae realm is used for a long time
The ability that food can make enteron aisle gradually lose self-reproduction beneficial bacterium, human body intestinal canal regulatory function can obviously weaken over time,
And then human health is damaged, or body is caused to generate adverse reaction, bacillary and fungoid septicopyemia such as occurs, promotes to have
Evil metabolic activity, overstimulation is immune, gastrointestinal reaction and gene transfer etc..
Such as: the Chinese invention patent of Publication No. CN201010292562.X discloses a kind of improvement human body intestinal canal flora
The drug and preparation method of balance, drug include following component: with 4-10 parts of dried orange peel, frying Semen Lablab Album 10-30 parts, Fu Ling 10-30
Part, 5-20 parts of wrinkled giant hyssop, 7-25 parts of lotus leaf, the extract that 7-25 parts of dandelion are raw material;And 200-400 parts of oligofructose;
The above are components by weight percent proportion, shiftings etc..The drug for human body intestinal canal flora balance that the invention provided improve with the energy of ultrasonic wave,
It dissolves out the effective component of vegetable drug in solution, is aided with oligofructose made from modern science as prebiotics, removes people
The damp and hot virulence factor of body, to achieve the purpose that Fast-Balance human body intestinal canal flora;And Publication No.
The Chinese invention patent of CN201210336538.0 disclose a kind of levulan extract preparation improve intestinal flora drug,
Application in food or health care product, the molecular weight ranges of the levulan extract are made with the following method 2000~10000
: Zhejiang is produced into Radix Ophiopogonis (Zhejiang Radix Ophiopogonis) root tuber first and extracts removal of impurities through ethyl alcohol, is then extracted with water, after ethanol precipitation,
A kind of levulan extract of drying to obtain (in 2000~10000 range of molecular weight).It is examined using Central obesity mouse model
Examine the function of the levulan extract, it was demonstrated that the levulan extract has the effect for being significantly improved intestinal flora.
Above-mentioned patent individually discloses the Chinese medicine and Western medicine for improving intestinal flora, and all has certain drug effect, but
It is the non-natural green food of the two, there are long term usages easily to have an impact to normal flora in enteron aisle, reduces intestinal regulatory function
And the problem that medication crowd is limited.
Summary of the invention
It is an object of the invention to overcome defect described in the prior art, to provide a kind of pure natural for improving
Compound solid beverage of intestinal flora and preparation method thereof.The compound solid beverage can not only improve the numerous of beneficial bacterium in enteron aisle
It grows, and long-term consumption will not influence other normal floras.
To achieve the goals above, the present invention provides the following technical solutions as follows:
It is a kind of for improving the compound solid beverage of intestinal flora, the raw material including following parts by weight:
200-800 parts of oligofructose, lactic acid bacteria compound powder 100-500 parts, 80-520 parts of maltitol, xylitol 80-520
Part, 66-264 parts of taro powder, 40-160 parts of raspberry powder, 40-160 parts of blackcurrant powder, 40-160 parts of strawberry powder, synthetism rasp berry fruit powder
4-16 parts, 8-32 parts of A Sayi fruit powder, 12-48 parts of Noni fruit powder, 8-32 parts of Cranberry powder, 8-32 parts of blueberry powder.
Preferably: above-mentioned for improving the compound solid beverage of intestinal flora, the raw material including following parts by weight: oligomeric fruit
240-640 parts sugared, lactic acid bacteria compounds powder 120-400 parts, 96-416 parts of maltitol, 96-416 parts of xylitol, taro powder 79.2-
211.2 parts, 48-128 parts of raspberry powder, 48-128 parts of blackcurrant powder, 48-128 parts of strawberry powder, synthetism rasp berry fruit powder 4.8-12.8
Part, 9.6-25.6 parts of A Sayi fruit powder, 14.4-38.4 parts of Noni fruit powder, 9.6-25.6 parts of Cranberry powder, blueberry powder 9.6-25.6
Part.
Preferably: above-mentioned for improving the compound solid beverage of intestinal flora, the raw material including following parts by weight: oligomeric fruit
Sugar 500 parts, lactic acid bacteria compounding 300 parts of powder, 300 parts of maltitol, 300 parts of xylitol, 330 parts of taro powder, 100 parts of raspberry powder,
100 parts of blackcurrant powder, 100 parts of strawberry powder, 10 parts of synthetism rasp berry fruit powder, 20 parts of A Sayi fruit powder, 30 parts of Noni fruit powder, Cranberry
20 parts of powder, 20 parts of blueberry powder.
Preferably: it is above-mentioned for improving the compound solid beverage of intestinal flora, it further include the mixing certain kind of berries perfume of 1-8 parts by weight
Essence.
Further: the lactic acid bacteria compounding powder includes lactic acid Bifidobacterium Bi-07,4- of 2.664-3.996wt%
The bifidobacterium lactis HM019's and 86.008-90.672wt% of lactobacillus acidophilus NCFM, 2.664-3.996wt% of 6wt%
Oligofructose.
Further: the lactic acid bacteria compounding powder includes the thermophilic of lactic acid Bifidobacterium Bi-07,5wt% of 3.33wt%
The oligofructose of the bifidobacterium lactis HM019 and 88.34wt% of Lactobacillus lactis NCFM, 3.33wt%.
Preferably: the taro powder the preparation method comprises the following steps:
A. cutting is the glycan grain of 9-12mm after fresh glycan being removed the peel;
B. the glycan grain is air-dried into dehydration to water content and is not more than 40wt%, it is dry to obtain glycan;
C. carry out low temperature pressurizing and ageing for the glycan is dry, wherein the temperature of the curing be at 80-100 DEG C, it is described ripe
The pressure of change is 101.3-202.6KP, by the dry air-cooled dehydration of progress of glycan after curing, until water content is not more than 15wt%,
It is dry that glycan must be dehydrated;
D. the dehydration glycan dry powder is broken to fineness no more than 246um to get taro powder.
Preferably: the raspberry powder the preparation method comprises the following steps:
S1: it is sliced after fresh raspberry cleaning is drained, microwave drying is then carried out at 65-70 DEG C, wherein when dry
Between be 10-13min, it is dry to obtain raspberry;
S2: the raspberry is done to the quick-frozen 2-2.5min of liquid nitrogen spraying of -180--160 DEG C of use, is then lyophilized, is obtained again
It is dry to freeze raspberry;
S3: the freezing raspberry dry powder is broken to fineness no more than 246um to get raspberry powder;
Wherein, the blackcurrant powder, strawberry powder, synthetism rasp berry fruit powder, A Sayi fruit powder, Noni fruit powder, Cranberry powder with
And the preparation method of blueberry powder is identical as the preparation method of the raspberry powder.
Further: the vacuum degree of freeze-drying described in step S2 is 0.1-0.5KPa, and condenser temperature is -30 DEG C, heating temperature
Degree is 35-40 DEG C, heating time 2-3h.
A method of the compound solid beverage for improving intestinal flora is prepared, is included the following steps:
(1) the synthetism rasp berry fruit powder, A Sayi fruit powder, Noni fruit powder, Cranberry powder and blueberry powder are mixed into 25-
35min obtains the first mixed powder;
(2) first mixed powder is compounded into powder, maltose with the raspberry powder, blackcurrant powder, strawberry powder, lactic acid bacteria
Alcohol, xylitol, taro powder and oligofructose mixing 1.8-2.2h are to get the compound solid beverage.
Oligofructose is also known as fructooligosaccharide, refers to that 2-5 fructosyl is chain link, using a glucosyl group as the end of chain
Base, skeleton links the carbohydrate to be formed based on fructosyl → fructose connecting key.Refer to 1-4 fructosyl with β -2,
The ketose that 1 key connection is formed on the D-Fructose base of sucrose
(GF2), the mixture of six sugar (GF5) of Nystose (GF3), sugarcane sugar (GF4) and sugarcane fruit.Oligofructose is one
Kind natural active matter, sugariness are 0.3-0.6 times of sucrose, have not only maintained the pure sweetening characteristics of sucrose, but also than sucrose sweet taste
Clearly, it is to have to adjust intestinal flora, is proliferated Bifidobacterium, promotes the absorption of calcium, adjust blood lipid, immunological regulation, anti-caries tooth etc.
The novel sweetener of healthcare function, after human body takes in oligofructose, oligofructose by Bifidobacterium absorption, (seldom can by oligofructose
By in alimentary canal gastric acid and enzyme decompose, it is extremely difficult to be absorbed by the body), Bifidobacterium is proliferated rapidly, internal profitable strain bifid bar
Bacterium number amount can inhibit external source pathogenic bacteria and the intrinsic putrefactivebacteria of enteral such as salmonella, Escherichia coli and clostruidium etc. is rotten
The growth and breeding of bacterium is lost, reduces the generation and accumulation of enteral toxic metabolites (such as indoles, nitroso ammonia), while rapidly by toxicity
Metabolin excretes, promote intestines peristalsis, mitigate burden of liver, prevent constipation and diarrhea, play the role of it is liver-protective, in advance
The effects of preventing various chronic diseases, cancer is obvious.
Lactic acid bacteria (lactic acid bacteria, LAB) is that one kind can be generated largely using fermentable carbohydrate
The common name of the bacterium of lactic acid, refer to fermenting carbohydrate primary product be lactic acid it is a kind of without gemma, gram-positive bacterium it is total
Claim, be prokaryotes, all bacteriums that can generate lactic acid from the fermentation process of glucose or lactose are referred to as lactic acid bacteria, this is
The quite numerous and jumbled bacterium of a group can at least be divided into 18 categories at present, share more than 200 kinds, and common lactic acid bacteria, vigor is extremely weak, it
Can only survive in relatively limited environment, once being detached from these environment, its own can also be destroyed.Only pass through special work
The lactic acid bacteria of skill processing gets to enteron aisle, into the lactic acid bacteria of enteral, it is necessary to it is more, energetic to have quantity, competence exertion its
Biological effect.Lactic acid bacteria can promote growth of animal, adjust composition of gut flora, maintain microecological balance, to improving stomach and intestine
Road function;Improve food digestion rate and biological value;Serum cholesterol is reduced, endotoxin is controlled;Inhibit spoilage organisms in enteron aisle raw
It is long, improve immunity of organisms etc..
All parasitism has a large amount of microorganisms to the entire alimentary canal of animal under normal circumstances.For its effect, three can be divided into
Class: 1. symbiosis type, mainly facultative anaerobic bacteria, in the ecological balance, their synthesis of vitamin and protein, digestion is inhaled
Receive, biological antagonist and the functions such as immune it is advantageous to host.2. pathogenic type, quantity is few under normal circumstances, parasitizes normal portion
Position, is unlikely to that host is made to fall ill.If out of control, the adverse reaction of host will lead to.3. intermediateness type has physiology simultaneously
With two kinds of effects of causing a disease.The balance of micropopulation, it is particularly significant to the health of body, and lactic acid bacteria can adjust this micro- life
State balance, ensures host's normal physiological condition.Lactic acid bacteria is enteron aisle often in bacterium, after livestock and poultry take lactic acid bacteria, thus it is possible to vary enteron aisle
Interior environment inhibits harmful bacteria breeding, adjustment gastrointestinal bacterial flora balance.Lactic acid bacteria is closely tied by adhesin with protection of intestinal mucosal barrier cells
It closes, is colonized occupy-place on intestinal mucosa surface, becomes the chief component of physiologic barrier, to reach recovery host resistance, repair
Multiple intestinal flora barrier, the effect for curing intestines problem.If this barrier is by the destruction of antibiotic or other factors, host
The position that can make the enteral bacterium abnormality proliferation with drug resistance to foreign bacteria resistance and replace dominant bacteria is lost, intestines are caused
The imbalance of microecological balance in road.
Maltitol is a kind of novel functional sweetener also known as hydrogenated maltose, and chemical name is the Portugal 4-O- α-D-
Grape glycosyl-D- glucitol, molecular formula C12H24O11, relative molecular mass 344.31.Maltitol is white crystalline powder
Or colorless and transparent neutral thick liquid, it is soluble easily in water, do not dissolve in methanol and ethyl alcohol.The sugariness of maltitol is sucrose
85%-95% has the characteristics that heat resistance, acid resistance, moisture retention and non-fermented, does not play Maillard reaction substantially.Malt
Sugar alcohol cannot almost decompose in human body for saliva, gastric juice, small goldbeater's skin enzyme etc., and calorific value is only the 5% of sucrose, take in human body
In interior maltitol, about 10% is used as using energy source after small intestine is decomposed and absorbed;Remaining 90% big enteral bacterium make
Short chain fatty acids are decomposed under, a part is utilized by intestinal bacterium, but is not easy to be utilized by mould, yeast and lactic acid bacteria, can be prevented
Saprodontia, remaining can not digest and excrete.
Xylitol is also known as pentitol, molecular formula C5H12O5, be a kind of five-state controller, xylitol be from silver birch, Oak Tree,
A kind of natural sweetener extracted in the plant materials such as corncob, bagasse is widely present in various water fruits and vegetables, paddy
Among class, commodity xylitol is carried out the agricultural crops such as corncob, bagasse prepared by deep processing, is a kind of natural, strong
The sweetener of health, xylitol sugariness is suitable with sucrose, is dissolved in absorbable amount of heat when water, is absorbed heat in all sugar alcohol sweeteners
It is worth maximum one kind, xylitol cannot be produced cariogenic bacterial fermentation and be utilized in oral cavity, can inhibit streptococcus growth and acid
It generates, it is not cariogenic and play the role of anti-caries.Xylitol is the intermediate of human body carbohydate metabolism, lacks insulin influence in vivo
In the case of glycometabolism, promote without insulin, xylitol can also penetrate cell membrane, be absorbed by tissue utilization, and liver glycogen is promoted to close
At, for cell with nutrition and energy, and blood glucose value will not be caused to increase, eliminate more than three symptoms after diabetes patient takes (more foods,
More drinks, diuresis), it is the sugar substitutes for being most suitable for the trophism of patients with diabetes mellitus.
Glycan alias perfume (or spice) ginseng, chestnut, native goldenrain tree, taro powder extract effective nutritional ingredient in glycan, remain original
The nutritive value of glycan, and be allowed to more easily store, save because having sloughed extra moisture, concentration is higher.On the market now
Existing taro powder it is general have two classes: the first kind is " pure taro powder " (such to can be collectively referred to as original powder), that is, directlys adopt glycan
Powder is that raw material does not add pure natural 100% product of any additive in addition to carrier.Second class is on the basis of a kind of taro powder
It is upper to add such as: white sugar, the product of edible essence;Product content such in this way lowers significantly, so advantage of lower cost, price
It can be cheaper.The taro powder use herein arrived is the original powder described in the first, and glycan is starch-containing 78.55%, protein
7.26%, polysaccharide 5%, also containing crude fibre, carrotene, thiamine, ash content, calcium, phosphorus, iron, selenium, riboflavin, niacin, anti-bad
Hematic acid etc., food have scattered plot qi-regulating, removing toxic substances tonifying spleen, reducing fever relieving cough drug effect.Glycan in glycan can enhance the immunization machine of human body
System, increases the resistance to disease, and long-term consumption can detoxify, nourish the body.Taro powder can restore enteron aisle PH numerical value, enteron aisle PH
After value restores normal, the flora in enteron aisle is more healthy, reduces the generation of cancer in enteron aisle.
Raspberry scientific name is Rubus corchorifolius (Rubus corchorifolius L.f.) also known as mountain throws son, milk bubble, spreads seedling bubble, three
Month bubble, April bubble, dragon-boat bubble, barley bubble, bubble youngster thorn, pierce cucurbit, steamed bun spinach, high foot wave, have the supporing yang improving eyesight of arresting seminal emission kidney-nourishing, wake up
The effect of wine quenches the thirst, resolving sputum is detoxified, cure mainly the diseases such as kidney deficiency, spermatorrhea, drunk, erysipelas.Leaf slight bitter, removing toxic substances, detumescence, sore etc.,
The diseases such as abscess of throat, multiple abscess, mazoitis.Raspberry powder extracts effective nutritional ingredient in raspberry, remains original raspberry
Nutritive value, studies have shown that the flavonoids extracted from RubusidaeusL. and RubuschamaemorusL. plant, five
Flavonol, 4,5,7- trihydroxyflavones all have significant antibacterial action, and Tan Mingxiong etc. reports Parvifolius to large intestine
Bacillus, Pasteurella have apparent bacteriostatic activity, and minimal inhibitory concentration (MIC) can be complete in the case of 10g/mL, 10g/mL
Inhibit the breeding of bacillus, bacteriostatic activity is better than control drug streptomysin and sulfa drugs.
Blackcurrant scientific name blackcurrant (Ribes nigrum L.), also known as non-irrigated grape, semen sojae atricolor, black fruit tea Fischer, craze for Japanese pop culture one are breathed out
It reaches, currant, elements of black currant, blackcurrant fruit is rich in multivitamin, carbohydrate and organic acid etc., especially Vitamin C content
It is higher, considerable sylvite and magnesium salts are contained in blackcurrant fruit, the major function of sylvite is to reinforce the excitability of muscle, is stablized
It is not normal to change rule for heart muscle cell membrane;Containing the bioflavonoid of higher amount in blackcurrant fruit, artery sclerosis journey can be effectively reduced
Degree, keeps the angiomalasia to become fragile thinning, improves the permeability of blood vessel, can prevention of arterial it is athero- hard, as the substance of anti-aging,
Nucleus formation with blocking nitrosamine formation has antioxidation, and Ascorbic Acid also has synergistic effect.With the prevention and treatment heart
The effect of cranial vascular disease and there is anticancer activity, while having very strong cancer-preventing health effectiveness.
Strawberry also known as the foreign certain kind of berries, the certain kind of berries, fruit, the red certain kind of berries, Strawberry, strawberry nutrition value is abundant, is known as being " fruit emperor
Afterwards ", vitamin C rich in, VitAVitE, nicotinic acid, vitamin B1, vitamin B2, carrotene, tan
The nutriments such as acid, aspartic acid, copper, strawberry amine, pectin, cellulose, folic acid, iron, calcium, ellagic acid and anthocyanidin.Especially
Contained vitamin C, content are all 7-10 times higher than apple, grape.And contained malic acid, citric acid, vitamin B1, dimension life
Plain B2 and carrotene, calcium, phosphorus, the content of iron are also 3-4 times higher than apple, pears, grape.It is fine rich in diet abundant in strawberry
Dimension can promote the wriggling of gastrointestinal tract, promote the food digestion in gastrointestinal tract, improve constipation, prevent the generation of acne, intestinal cancer.
Synthetism rasp berry are the fruit of elder (scientific name: Sambucus williamsii Hance), elder also known as justice
Always, pubescent angelica root, horse urine disturb, intermediate torricellia root and leaf, most important ingredient is polyphenol compound in synthetism rasp berry, including anthocyan and
Flavonoids.Synthetism rasp berry also contain vitamin, minerals, amino acid and sterols, and identifiable substance includes vitamin A, dimension
Raw element C, iron, play antioxidant also rich in, and resistance to oxidation is 20 times of Vit C, and 50 times of Vit E, except this has
Synthetism rasp berry also have effects that antiviral and improve immunity except nutritional ingredient.
Ah's Say, also known as not old fruit, the best soldier of free radical, life fruit, A Sayi berry, compatriots are referred to as the Brazilian certain kind of berries,
Natural nutrient component and antioxidant content rich in, including Omega3 fatty acid (required fatty acid, to health ten
It is point important, but human body voluntarily can not be manufactured effectively), amino acid, minerals, needs crucial vitamin and fiber.Brazil
The certain kind of berries can help the vigor of renewing one's youth, cleaning toxin expelling, wound healing, purify the blood, improves anaemia, diarrhea, fever, bleeding, jaundice, liver
Disease, helminth and ulcer.
Noni fruit (Noni) is the fruit of beach wood Morinda offcinalis How.Its fruit has the composition rich in human body cell body cell, has
The effect of salubrity.Noni extract is safe natural, has antioxidant activity and protection myocardial cells effect,
Adjustable damaged myocardium cellular energy metabolism, delays heart failure process.
Cranberry is also known as cranberry, mossberry, cranberry, european cranberry, climing more plum, the crane certain kind of berries, and Cranberry contains special chemical combination
Object-condensed tannins, Cranberry help to inhibit a variety of pathogenic bacterias to grow and breeding, prevent these pathogenic bacteria and thin in vivo
Born of the same parents' (such as urothelial cell) are sticked, and are prevented and are controlled women's urethral infection and inhibit to lead to gastric ulcer even stomach
The infection of the helicobacter pylori of carcinogenesis;It assists in keeping the integrality of the bladder wall simultaneously and maintains the normal pH value of urethra.
Blueberry English name: Blueberry, alias indigo plant plum, bog bilberry, sincere persimmon, beep thermophilic, bilberry, pasture fruit, great bilberry are blue
In certain kind of berries fruit other than conventional sugar, acid and Vc, it is rich in VE, VA, VB, SOD, arbutin, protein, anthocyanin, dietary fibre
And the mineral elements such as K, Fe, Zn, Ca abundant.According to small berries research institute, Jilin Agriculture University to 14 indigo plants of overseas introduction
Certain kind of berries variety analysis, anthocyanin pigments content is up to 163mg/100g, fresh fruit VE content 9.3L in fruit | and g/100g fresh fruit is it
Even tens times of several times of his fruit such as apple, grape.Total amino acid content 0.254%, hawthorn more abundant than amino acid content
It is also high.Nutritional ingredient rich in Blueberry, having prevents cranial nerve aging, protection eyesight, heart tonifying, anticancer, softening
Blood vessel such as enhances the immune of the body at the functions, and nutritional ingredient is high, and water-soluble dietary fiber can promote intestines peristalsis in blueberry, prevents
It treats constipation, fruit has convergence, heat-clearing and other effects, and being used as medicine can stomach strengthening and digestion promoting, only diarrhea.
Essence is by the concentration aromatic oil of artificial synthesized imitation fruit and natural perfume material smell, it is a kind of artificial musk
Material, primary raw material are essential oil, medicinal extract, absolute oil, balm, botany bar gum, oleoresin, and essence is at least by several spice materials or even several
Ten kinds of natural and synthetic perfume composition or organic compound complexs.Used herein arrive is mixing certain kind of berries essence, used
Raw material is natural perfume material.The allotment of essence can be by forming as follows: 1. perfume base-shows the main body of odor type feature;2. blender-
By reconcile various composition fragrance for the purpose of ingredient;3. dressing agent-makes the ingredient of essence variation style;4. fixation type-itself
It is not volatile, and the volatility of other volatile fragrance can be inhibited, slows down its volatilization;5. diluent-is suitably fragrance
Desalinate and dissolution and dilution is made to crystallization fragrance and resin-like face cream, itself answers odorless, stable, safety and price is low.
The invention has the benefit that
(1) compound solid beverage of the invention is used to improve intestinal flora, can improve constipation, promote digestion, builds up health,
Pharmacology of the invention are as follows: firstly, taro powder, raspberry powder, blackcurrant powder, strawberry powder, synthetism rasp berry fruit powder in the application prescription,
Dietary fiber rich in Ah's Say fruit powder, Noni fruit powder, Cranberry powder and blueberry powder, can promote intestines peristalsis, clearly
Intestines toxin expelling improves constipation;Secondly, being rich in various vitamins, especially vitamin C in these above-mentioned fruit powders, it can build up health, subtract
Few sick probability;In addition to this, the oligofructose in this prescription can be obviously improved the ratio of microbial population in enteron aisle, increase
The quantity of enteral Bifidobacterium reduces and inhibits the generation of enteral corrupt substance and the growth of harmful bacteria, and then adjusts intestines
Road inner equilibrium;In addition it also added lactic acid bacteria compounding powder in this prescription, lactic acid bacteria compounds the lactic acid bacteria containing multiple types in powder, respectively
Type lactic acid bacteria effectively supplement different users because caused by sick or the age growth lactic acid bacteria losing issue or because
Flora unbalance in human body intestinal canal caused by the long-term use of wide spectrum strength antibiotic based on lactic acid bacteria, it is domestic at present
Exobiology man it has proven convenient that in human body lactic acid bacterium number actual state, have become and examine the weight whether had good health and a long life of people
Want index, lactic acid bacteria increased and can gradually decrease with the age of people, when people to old age or it is sick when, lactic acid bacterium number may decline
It 100 to 1000 times, is completely disappeared until the elderly is approaching one's end.Usually, for Healthy People 50 times more than patient, long lived elder is older than common
People is 60 times more;And beneficial flora is unbalance, will lead to resistance of human body gradually declines, and disease the more is controlled the more more, and health status is gradually
Decline;This prescription lactic acid bacteria compounding powder other than lactic acid bacteria is supplemented and is adjusted, also cooperate with above-mentioned various fruit powders and
Oligofructose, maltitol and xylitol adjust gastrointestinal bacterial flora, enhancing intestines peristalsis jointly, improve constipation, significant in efficacy;
Each component is natural material in this product, and pure in mouth feel is suitable for all kinds of enteron aisle discomfort people's constitutions, and safety is without side-effects,
It can take for a long time;
(2) taro powder manufacturing process of the invention first carries out fresh glycan to air-dry crushing, phase after maturation process again
Crush efficiency is high for the preparation method of traditional taro powder, it is high-quality to crush;In addition condition of the present invention in low temperature pressurization
Under cured, not only can be to avoid high temperature too early dusting to the destruction of taro meal collastromin, but also can guarantee obtained
Finished product retains the fragrance of fresh glycan;
(3) raspberry powder of the invention, blackcurrant powder, strawberry powder, synthetism rasp berry fruit powder, A Sayi fruit powder, Noni fruit powder, climing
More certain kind of berries powder and blueberry powder, preparation method thereof is identical, is all made of microwave drying, liquid nitrogen flash freezer and vacuum freeze drying and be combined with each other, real
Processing now is dried and dehydrated to certain kind of berries fruit at a lower temperature, so that the nutrition composition in fruit powder obtained is not destroyed, is improved
The nutritive value of fruit powder;
(4) method that compound solid beverage of the invention uses equal increments during the preparation process is mixed, specific to grasp
It is as method: the component for taking the amount of a small amount of component and equivalent big, while being placed in mixing machinery and being uniformly mixed, it adds with mixed
The component that the amount of conjunction object equivalent is big is uniformly mixed, and so a times amount is increased up until adding the big component of whole amount.The present invention adopts
With equal increments method carry out that mixing can make that ratio differs greatly in inventive formulation each ingredient mixes more evenly and save
Save incorporation time.
Detailed description of the invention
In order to more clearly explain the embodiment of the invention or the technical proposal in the existing technology, to embodiment or will show below
There is attached drawing needed in technical description to be briefly described, it should be apparent that, the accompanying drawings in the following description is only this
Some embodiments of invention for those of ordinary skill in the art without creative efforts, can be with
Other attached drawings are obtained according to these attached drawings.
Fig. 1 is the process flow diagram of the embodiment of the present invention.
Specific embodiment
Technical solution of the present invention is clearly and completely described below in conjunction with attached drawing, it is clear that described implementation
Example is a part of the embodiment of the present invention, instead of all the embodiments.Based on the embodiments of the present invention, ordinary skill
Personnel's every other embodiment obtained without making creative work, shall fall within the protection scope of the present invention.
It should be noted that in the following embodiments 1 part of generation refer to 1g, wherein oligofructose is had by the bright moral biotechnology in Xi'an
Limit company provides;Maltitol is provided by Nanjing Corning Chemical Co., Ltd.;Xylitol is had by Shandong dragon power biotechnology share
Limit company provides;Lactic acid Bifidobacterium Bi-07 and bifidobacterium lactis HM019 is by the Xi'an biotech inc Ze Lang
(former Tai Yuzhiti factory) provides;Lactobacillus acidophilus NCFM is provided by Danisco (China) Co., Ltd;Certain kind of berries essence is mixed by sweet smell
Kindness fragrance (China) Co., Ltd provides;
Embodiment 1
The present invention provides a kind of for improving the compound solid beverage of intestinal flora, the raw material including following parts by weight:
200 parts of oligofructose, 100 parts of powder of lactic acid bacteria compounding, 80 parts of maltitol, 80 parts of xylitol, 66 parts of taro powder, tree
40 parts of certain kind of berries powder, 40 parts of blackcurrant powder, 40 parts of strawberry powder, 4 parts of synthetism rasp berry fruit powder, 8 parts of A Sayi fruit powder, 12 parts of Noni fruit powder,
8 parts of Cranberry powder, 8 parts of blueberry powder;
Wherein, lactic acid bacteria compounding powder includes the lactobacillus acidophilus of lactic acid Bifidobacterium Bi-07,4wt% of 2.664wt%
The oligofructose of the bifidobacterium lactis HM019 and 90.672wt% of NCFM, 2.664wt%;
The present invention also provides the methods for preparing the above-mentioned compound solid beverage for being used to improve intestinal flora, including walk as follows
It is rapid:
(1) taro powder is prepared
A. cutting is the glycan grain of 9mm after fresh glycan being removed the peel;
B. the glycan grain is air-dried dehydration to water content is 40wt%, and it is dry to obtain glycan;
C. carry out low temperature pressurizing and ageing for the glycan is dry, wherein the temperature of the curing be at 80 DEG C, the curing
Pressure is 101.3KP, and it is dry must to be dehydrated glycan until water content is 15wt% for the dry air-cooled dehydration of progress of glycan after curing;
D. the dehydration glycan dry powder is broken to fineness is 246um to get taro powder;
(2) raspberry powder, blackcurrant powder, strawberry powder, synthetism rasp berry fruit powder, A Sayi fruit powder, Noni fruit powder, Cranberry are prepared
Powder and blueberry powder, preparation method is consistent, now by taking raspberry powder as an example, it is specific the preparation method is as follows:
S1: being sliced after fresh raspberry cleaning is drained, microwave drying then carried out at 65 DEG C, wherein drying time be
It is dry to obtain raspberry by 10min;
S2: the raspberry is done to the quick-frozen 2min of liquid nitrogen spraying of -180 DEG C of use, is then lyophilized again, raspberry must be freezed
It is dry;
S3: it is 246um to get raspberry powder that the freezing raspberry dry powder, which is broken to fineness,;
(3) compound solid beverage for improving intestinal flora is prepared
1. by above-mentioned parts by weight weigh synthetism rasp berry fruit powder, A Sayi fruit powder, Noni fruit powder, Cranberry powder, blueberry powder and
Certain kind of berries essence is mixed, the first time that each raw material carries out 25min is mixed, the first mixed powder is obtained;
2. weighing raspberry powder, blackcurrant powder, strawberry powder, lactic acid bacteria by above-mentioned parts by weight compounds powder, maltitol, xylose
Alcohol, taro powder and oligofructose, and mixed with second of above-mentioned first mixed powder progress 1.8h, complex solid can be obtained
Beverage.
Embodiment 2
It is a kind of for improving the compound solid beverage of intestinal flora, the raw material including following parts by weight:
240 parts of oligofructose, lactic acid bacteria compounding 120 parts of powder, 96 parts of maltitol, 96 parts of xylitol, 79.2 parts of taro powder,
48 parts of raspberry powder, 48 parts of blackcurrant powder, 48 parts of strawberry powder, 4.8 parts of synthetism rasp berry fruit powder, 9.6 parts of A Sayi fruit powder, Noni fruit powder
14.4 parts, 9.6 parts of Cranberry powder, 9.6 parts of blueberry powder, 1 part of certain kind of berries essence of mixing.
Wherein, lactic acid bacteria compounding powder includes the lactobacillus acidophilus of lactic acid Bifidobacterium Bi-07,4.5wt% of 2.997wt%
The oligofructose of the bifidobacterium lactis HM019 and 89.506wt% of NCFM, 2.997wt%;
As shown in Figure 1, it is above-mentioned for improving the method for the compound solid beverage of intestinal flora the present invention also provides preparing,
Include the following steps:
(1) taro powder is prepared
A. cutting is the glycan grain of 10mm after fresh glycan being removed the peel;
B. the glycan grain is air-dried dehydration to water content is 38wt%, and it is dry to obtain glycan;
C. carry out low temperature pressurizing and ageing for the glycan is dry, wherein the temperature of the curing be at 85 DEG C, the curing
Pressure is 121.56KP, and the dry air-cooled dehydration of progress of glycan after curing is obtained dehydration glycan until water content is not 14wt%
It is dry;
D. the dehydration glycan dry powder is broken to fineness is 149um to get taro powder;
(2) raspberry powder, blackcurrant powder, strawberry powder, synthetism rasp berry fruit powder, A Sayi fruit powder, Noni fruit powder, Cranberry are prepared
Powder and blueberry powder, preparation method is consistent, now by taking raspberry powder as an example, it is specific the preparation method is as follows:
S1: being sliced after fresh raspberry cleaning is drained, microwave drying then carried out at 66 DEG C, wherein drying time be
It is dry to obtain raspberry by 11min;
S2: the raspberry is done to the quick-frozen 2.2min of liquid nitrogen spraying of -175 DEG C of use, is then lyophilized again, raspberry must be freezed
It is dry;
S3: it is 149um to get raspberry powder that the freezing raspberry dry powder, which is broken to fineness,;
(3) compound solid beverage for improving intestinal flora is prepared
1. by above-mentioned parts by weight weigh synthetism rasp berry fruit powder, A Sayi fruit powder, Noni fruit powder, Cranberry powder, blueberry powder and
Certain kind of berries essence is mixed, the first time that each raw material carries out 28min is mixed, the first mixed powder is obtained;
2. weighing raspberry powder, blackcurrant powder, strawberry powder, lactic acid bacteria by above-mentioned parts by weight compounds powder, maltitol, xylose
Alcohol, taro powder and oligofructose, and mixed with second of above-mentioned first mixed powder progress 1.9h, complex solid can be obtained
Beverage.
Embodiment 3
It is a kind of for improving the compound solid beverage of intestinal flora, the raw material including following parts by weight:
500 parts of oligofructose, lactic acid bacteria compound 300 parts of powder, 300 parts of maltitol, 300 parts of xylitol, taro powder 330
Part, 100 parts of raspberry powder, 100 parts of blackcurrant powder, 100 parts of strawberry powder, 10 parts of synthetism rasp berry fruit powder, 20 parts of A Sayi fruit powder, Nuo Li
30 parts of fruit powder, 20 parts of Cranberry powder, 20 parts of blueberry powder, 4.5 parts of certain kind of berries essence of mixing;
Wherein, lactic acid bacteria compounding powder includes the lactobacillus acidophilus of lactic acid Bifidobacterium Bi-07,5wt% of 3.33wt%
The oligofructose of the bifidobacterium lactis HM019 and 88.34wt% of NCFM, 3.33wt%;
As shown in Figure 1, it is above-mentioned for improving the method for the compound solid beverage of intestinal flora the present invention also provides preparing,
Include the following steps:
(1) taro powder is prepared
A. cutting is the glycan grain of 10mm after fresh glycan being removed the peel;
B. the glycan grain is air-dried dehydration to water content is 36wt%, and it is dry to obtain glycan;
C. carry out low temperature pressurizing and ageing for the glycan is dry, wherein the temperature of the curing be at 90 DEG C, the curing
Pressure is 162.08KP, and the dry air-cooled dehydration of progress of glycan after curing is obtained dehydration glycan until water content is not 13wt%
It is dry;
D. the dehydration glycan dry powder is broken to fineness is 74um to get taro powder;
(2) raspberry powder, blackcurrant powder, strawberry powder, synthetism rasp berry fruit powder, A Sayi fruit powder, Noni fruit powder, Cranberry are prepared
Powder and blueberry powder, preparation method is consistent, now by taking raspberry powder as an example, it is specific the preparation method is as follows:
S1: being sliced after fresh raspberry cleaning is drained, microwave drying then carried out at 68 DEG C, wherein drying time be
It is dry to obtain raspberry by 12min;
S2: the raspberry is done to the quick-frozen 2.3min of liquid nitrogen spraying of -170 DEG C of use, is then lyophilized again, raspberry must be freezed
It is dry;
S3: it is 74um to get raspberry powder that the freezing raspberry dry powder, which is broken to fineness,;
(3) compound solid beverage for improving intestinal flora is prepared
1. by above-mentioned parts by weight weigh synthetism rasp berry fruit powder, A Sayi fruit powder, Noni fruit powder, Cranberry powder, blueberry powder and
Certain kind of berries essence is mixed, the first time that each raw material carries out 28min is mixed, the first mixed powder is obtained;
2. weighing raspberry powder, blackcurrant powder, strawberry powder, lactic acid bacteria by above-mentioned parts by weight compounds powder, maltitol, xylose
Alcohol, taro powder and oligofructose, and mixed with second of above-mentioned first mixed powder progress 1.9h, complex solid can be obtained
Beverage.
Embodiment 4
It is a kind of for improving the compound solid beverage of intestinal flora, the raw material including following parts by weight:
640 parts of oligofructose, lactic acid bacteria compound 400 parts of powder, 416 parts of maltitol, 416 parts of xylitol, taro powder 211.2
Part, 128 parts of raspberry powder, 128 parts of blackcurrant powder, 128 parts of strawberry powder, 12.8 parts of synthetism rasp berry fruit powder, 25.6 parts of A Sayi fruit powder,
38.4 parts of Noni fruit powder, 25.6 parts of Cranberry powder, 25.6 parts of blueberry powder, 6.4 parts of certain kind of berries essence of mixing;
Wherein, lactic acid bacteria compounding powder includes the lactobacillus acidophilus of lactic acid Bifidobacterium Bi-07,5.5wt% of 3.663wt%
The oligofructose of the bifidobacterium lactis HM019 and 87.24wt% of NCFM, 3.663wt%;
As shown in Figure 1, it is above-mentioned for improving the method for the compound solid beverage of intestinal flora the present invention also provides preparing,
Include the following steps:
(1) taro powder is prepared
A. cutting is the glycan grain of 11mm after fresh glycan being removed the peel;
B. the glycan grain is air-dried dehydration to water content is 36wt%, and it is dry to obtain glycan;
C. carry out low temperature pressurizing and ageing for the glycan is dry, wherein the temperature of the curing be at 90 DEG C, the curing
Pressure is 182.34KP, and it is dry must to be dehydrated glycan until water content is 13wt% for the dry air-cooled dehydration of progress of glycan after curing;
D. the dehydration glycan dry powder is broken to fineness is 44um to get taro powder;
(2) raspberry powder, blackcurrant powder, strawberry powder, synthetism rasp berry fruit powder, A Sayi fruit powder, Noni fruit powder, Cranberry are prepared
Powder and blueberry powder, preparation method is consistent, now by taking raspberry powder as an example, it is specific the preparation method is as follows:
S1: being sliced after fresh raspberry cleaning is drained, microwave drying then carried out at 68 DEG C, wherein drying time be
It is dry to obtain raspberry by 12min;
S2: the raspberry is done to the quick-frozen 2.4min of liquid nitrogen spraying of -165 DEG C of use, is then lyophilized again, raspberry must be freezed
It is dry;
S3: it is 44um to get raspberry powder that the freezing raspberry dry powder, which is broken to fineness,;
(3) compound solid beverage for improving intestinal flora is prepared
1. by above-mentioned parts by weight weigh synthetism rasp berry fruit powder, A Sayi fruit powder, Noni fruit powder, Cranberry powder, blueberry powder and
Certain kind of berries essence is mixed, the first time that each raw material carries out 28min is mixed, the first mixed powder is obtained;
2. weighing raspberry powder, blackcurrant powder, strawberry powder, lactic acid bacteria by above-mentioned parts by weight compounds powder, maltitol, xylose
Alcohol, taro powder and oligofructose, and mixed with second of above-mentioned first mixed powder progress 1.9h, complex solid can be obtained
Beverage.
Embodiment 5
800 parts of oligofructose, lactic acid bacteria compound 500 parts of powder, 520 parts of maltitol, 520 parts of xylitol, taro powder 264
Part, 160 parts of raspberry powder, 160 parts of blackcurrant powder, 160 parts of strawberry powder, 16 parts of synthetism rasp berry fruit powder, 32 parts of A Sayi fruit powder, Nuo Li
48 parts of fruit powder, 32 parts of Cranberry powder, 32 parts of blueberry powder, 8 parts of certain kind of berries essence of mixing;
Wherein, lactic acid bacteria compounding powder includes the lactobacillus acidophilus of lactic acid Bifidobacterium Bi-07,6wt% of 3.996wt%
The oligofructose of the bifidobacterium lactis HM019 and 90.672wt% of NCFM, 3.996wt%;
As shown in Figure 1, it is above-mentioned for improving the method for the compound solid beverage of intestinal flora the present invention also provides preparing,
Include the following steps:
(1) taro powder is prepared
A. cutting is the glycan grain of 12mm after fresh glycan being removed the peel;
B. the glycan grain is air-dried dehydration to water content is 35wt%, and it is dry to obtain glycan;
C. carry out low temperature pressurizing and ageing for the glycan is dry, wherein the temperature of the curing be at 100 DEG C, the curing
Pressure is 202.6KP, and it is dry must to be dehydrated glycan until water content is 12wt% for the dry air-cooled dehydration of progress of glycan after curing;
D. the dehydration glycan dry powder is broken to fineness is 37um to get taro powder;
(2) raspberry powder, blackcurrant powder, strawberry powder, synthetism rasp berry fruit powder, A Sayi fruit powder, Noni fruit powder, Cranberry are prepared
Powder and blueberry powder, preparation method is consistent, now by taking raspberry powder as an example, it is specific the preparation method is as follows:
S1: being sliced after fresh raspberry cleaning is drained, microwave drying then carried out at 70 DEG C, wherein drying time be
It is dry to obtain raspberry by 13min;
S2: the raspberry is done to the quick-frozen 2.5min of liquid nitrogen spraying of -160 DEG C of use, is then lyophilized again, raspberry must be freezed
It is dry;
S3: it is 37um to get raspberry powder that the freezing raspberry dry powder, which is broken to fineness,;
(3) compound solid beverage for improving intestinal flora is prepared
1. by above-mentioned parts by weight weigh synthetism rasp berry fruit powder, A Sayi fruit powder, Noni fruit powder, Cranberry powder, blueberry powder and
Certain kind of berries essence is mixed, the first time that each raw material carries out 28min is mixed, the first mixed powder is obtained;
2. weighing raspberry powder, blackcurrant powder, strawberry powder, lactic acid bacteria by above-mentioned parts by weight compounds powder, maltitol, xylose
Alcohol, taro powder and oligofructose, and mixed with second of above-mentioned first mixed powder progress 1.9h, complex solid can be obtained
Beverage.
The pharmaceutical test of the embodiment of the present application 3 is given below:
Animal experiment
1, materials and methods
1.1 samples: the compound solid beverage for being used to improve intestinal flora obtained by the present embodiment 3.
1.2 animals: healthy adult female BAl BIc/C mice, weight 18-22g, by Huaxi Medical Univ's experimental animal center
It provides and (quality certification number: moves Guan Zhi 64 in fact in river).
1.3 culture mediums and condition of culture:
Bifidobacterium: using self-control BBL culture medium, the Anaerobic culturel 48-72h at 37 DEG C;
Wherein the ingredient of BBL culture medium includes peptone 15.0g, yeast powder 2.0g, glucose 20.0g, soluble starch
0.5g, sodium chloride 5.0g, 5% cysteine 10.0mL, tomato leachate 400.0mL, Tween 80 1.0mL, liver extracting solution
80.0mL, agar 20.0g, distilled water 520.0mL;Preparation method is to dissolve by heating above-mentioned composition, is sub-packed in built-in voltage regulator tube
In test tube, pH value should be 7.0 ± 0.1 at 25 DEG C after sterilizing;
Bacillus acidi lactici: self-designed L S culture medium, the Anaerobic culturel 48h at 37 DEG C are used;
Wherein LS culture medium includes ammonium nitrate l650mg/L, potassium nitrate 1900mg/L, CaCl2·2H2O 440mg/L、
MgSO4·7H2O 370mg/L、KH2PO4 170mg/L、Na2-EDTA 37.3mg/L、FeSO4·7H2O 27.8mg/L、H3BO3
6.2mg/L、MnSO4·4H2O 22.3mg/L、ZnSO4·7H2O 8.6mg/L, potassium iodide 0.83mg/L, Na2MoO·2H2O
0.25mg/L、CuSO4·5H2O 0.025mg/L、CoCl2·6H2O 0.025mg/L, vitamin Bl0.4mg/L, inositol
10.0mg/L, sucrose 30g/L;Preparation method is to dissolve by heating above-mentioned composition, is sub-packed in the test tube of built-in voltage regulator tube, after sterilizing
PH value should be 5.6 at 25 DEG C;It should be noted that FeSO4·7H2O is formulated as that 5.57g is taken to be first dissolved in 1 liter of distilled water, so
The ratio in every liter of culture medium containing 5mg is added in culture medium afterwards;Na2- EDTA is formulated as that 7.45g is taken to be first dissolved in 1 liter of distilled water
In, then the ratio in every liter of culture medium containing 5mg is added in culture medium;
Enterobacteria: it (is provided by Hangzhou microorganism reagent factory) using EMB culture medium, is cultivated for 24 hours at 37 DEG C;
Enterococcus: it using self-control EC culture medium, is cultivated for 24 hours at 37 DEG C;
Wherein EC culture medium includes tryptone or shows peptone 20.0g, lactose 5.0g, No. 3 cholate 1.5g, K2HPO4·3H2O
4.0g, potassium dihydrogen phosphate 1.5g, sodium chloride 5.0g, distilled water 1000mL;Preparation method is to dissolve by heating above-mentioned composition, is dispensed
In the test tube of built-in voltage regulator tube, pH value should be 6.9 after sterilizing, this culture medium should not be placed in refrigerator before using, to prevent occurring when detection
False positive;
C.perfringens: CD culture medium, the Anaerobic culturel 48h at 37 DEG C are used.
Wherein, CD culture medium is provided by Shanghai Jin Mai Biotechnology Co., Ltd.
1.4 experimental methods:
Animal sample is fed with 3d using basal feed, chooses 48 Healthy female BALB/C mices by random group forming criterion
It is divided into control group, low dose group, middle dose group and high dose group, wherein low dose group takes drugs to implement containing 2wt%
Compound solid beverage 33ml/kg described in example 3;Middle dose group takes drugs as containing 2wt% complex solid described in embodiment 3
Beverage 66ml/kg;High dose group takes drugs to be used for containing 2wt% compound solid beverage 99ml/kg described in embodiment 3
Each dosage group of experimental animal is successively equivalent to 10,20 and 30 times of Coming-of-Age Day recommended doses of recommendation.
Test group is with the compound solid beverage stomach-filling of above-mentioned dosage, and control group is with distilled water stomach-filling, once a day, continuous to fill
Stomach 14d, before stomach-filling and after stomach-filling 14d, aseptic collection stool in mice 0.1-0.4g, sets the drying with bead weighed and goes out respectively
It in bacterium small test tube, is re-weighed, calculates the weight of stool in mice, be added 10 times of sterile diluent thin liquid, vibrate 1min, it is sufficiently mixed
It is even, then successively carry out 10 times and be serially diluted, suitable dilution is selected, is seeded on each culture medium, is trained as required respectively
It supports, carries out analysis in groups by the difference of the logarithm of intestinal microflora each before and after stomach-filling.
2, result
Influence (being shown in Table 1) to four kinds of intestinal microfloras of mouse
Influence (log CFU/g, X ± SD, N=12) of 1 compound solid beverage of table to four kinds of intestinal microfloras of mouse
Note: * is that compared with the control group (P < 0.05), # is compared with the control group (P < 0.01)
3, it analyzes
As shown in Table 1, the complex solid of difference orally administration BALB/C mice low dose group, middle dose group, high dose group
Beverage 14d, compared with the control group, enterococcus, enterobacteria quantity there are no significant difference in each dosage group mouse intestinal;Low dose
Amount, high dose group Bacillus acidi lactici quantity obviously increase, and have significant difference (P < 0.05), and middle dose group Bacillus acidi lactici quantity increases
Significantly, there is highly significant difference (P < 0.01);Low dosage, middle dose group bifidobacteria obviously increase, and have conspicuousness poor
Different (P < 0.05).Illustrate that this compound solid beverage can be such that Bacillus acidi lactici in mouse intestinal, Bifidobacterium number increases, to mouse intestines
Road flora has improvement result.
Clinical test:
Human body intestinal canal flora detection test
1, it selects study subject: following physical examination: (1) blood, urine, feces routine inspection and liver function is carried out to tested volunteer
It checks;(2) test before test-meal is tested of heart rate, blood pressure, electrocardiogram, B ultrasound (liver, gallbladder, spleen, kidney) indices is primary.Selection 31
All normal tested volunteer tests as study subject and uses own control name (male 15, female 16) physical examination index.
2, test procedure: the compound solid beverage 200ml that the daily drinking quality score of study subject is 2% is continuously drunk
15d.It is sterile respectively that subject mixing stool about 10g is taken to set before test-meal tested material and after giving tested material last time for 24 hours
It in the dry sterilization conical beaker with bead of weighing, is re-weighed, calculates the weight of excrement, sterile diluent, dilution is added
10 times, 1min is vibrated, is mixed well, then successively carried out 10 times and be serially diluted, selected suitable dilution, be seeded in each training respectively
It supports on base, is cultivated as required.Pairing measurement data analysis is carried out by the logarithm of intestinal microflora, and subject is eaten
It is observed and is counted with front and back subjective symptoms.
3, experimental result
3.1, the influence to five kinds of intestinal microfloras of human body (being shown in Table 2).
2 human body intestinal canal flora testing result of table (logC FU/g, X ± SD, N=49)
Group | Enterobacteria | Enterococcus | Clostridium perfringens enterotoxin | Bifidobacterium | Bacillus acidi lactici |
Before drinking | 7.62±0.70 | 6.57±1.09 | 5.84±1.00 | 8.81±0.93 | 5.70±1.14 |
After drinking | 7.32±0.81 | 6.96±0.92 | 5.46±1.25* | 9.41±0.89* | 6.34±1.34* |
Note: * is (own control) P < 0.01 compared with drinking before tested material
3.2, tested crowd's subjective symptoms observation
After subject drinks tested material, all subjects have no adverse reaction, and 17 people's constipation situations have improvement, and 8 people have food
Phenomenon to be increased, 6 people's readmes exhaust increased.
4, interpretation of result
As shown in Table 2, tested crowd drinks compound solid beverage 15d of the invention, enterobacteria, intestines in tested Intestinal
Coccus quantity there are no significant difference;Bifidobacterium, Bacillus acidi lactici quantity increase it is significant, in highly significant difference (P <
0.01);Clostridium perfringens enterotoxin quantity reduces significantly, there is highly significant difference (P < 0.01).Illustrate that compound solid beverage of the invention can
Increase human body intestinal bifidobacteria, Bacillus acidi lactici quantity, clostridium perfringens enterotoxin quantity is reduced, and is had to improve to human body intestinal canal flora and be made
With.And by observing tested crowd's subjective symptoms, this product has improvement intestinal flora, improves constipation, constitutional effect.
The foregoing is merely a specific embodiment of the invention, but scope of protection of the present invention is not limited thereto, any
In the technical scope disclosed by the present invention, any changes or substitutions that can be easily thought of by those familiar with the art, all answers
It is included within the scope of the present invention.Therefore, protection scope of the present invention should be with the scope of protection of the claims
It is quasi-.
Claims (10)
1. a kind of for improving the compound solid beverage of intestinal flora, which is characterized in that the raw material including following parts by weight:
200-800 parts of oligofructose, lactic acid bacteria compound powder 100-500 parts, 80-520 parts of maltitol, 80-520 parts of xylitol,
66-264 parts of taro powder, 40-160 parts of raspberry powder, 40-160 parts of blackcurrant powder, 40-160 parts of strawberry powder, synthetism rasp berry fruit powder 4-
16 parts, 8-32 parts of A Sayi fruit powder, 12-48 parts of Noni fruit powder, 8-32 parts of Cranberry powder, 8-32 parts of blueberry powder.
2. compound solid beverage according to claim 1, which is characterized in that the raw material including following parts by weight:
240-640 parts of oligofructose, lactic acid bacteria compound powder 120-400 parts, 96-416 parts of maltitol, 96-416 parts of xylitol,
79.2-211.2 parts of taro powder, 48-128 parts of raspberry powder, 48-128 parts of blackcurrant powder, 48-128 parts of strawberry powder, synthetism rasp berry fruit
4.8-12.8 parts of powder, 9.6-25.6 parts of A Sayi fruit powder, 14.4-38.4 parts of Noni fruit powder, 9.6-25.6 parts of Cranberry powder, blueberry
9.6-25.6 parts of powder.
3. compound solid beverage according to claim 1, which is characterized in that the raw material including following parts by weight:
500 parts of oligofructose, 300 parts of powder of lactic acid bacteria compounding, 300 parts of maltitol, 300 parts of xylitol, 330 parts of taro powder, tree
100 parts of certain kind of berries powder, 100 parts of blackcurrant powder, 100 parts of strawberry powder, 10 parts of synthetism rasp berry fruit powder, 20 parts of A Sayi fruit powder, Noni fruit powder
30 parts, 20 parts of Cranberry powder, 20 parts of blueberry powder.
4. compound solid beverage according to claim 1, which is characterized in that further include the mixing certain kind of berries essence of 1-8 parts by weight.
5. compound solid beverage described in any one of -4 according to claim 1, which is characterized in that the lactic acid bacteria compounds powder packet
Include lactobacillus acidophilus NCFM, 2.664-3.996wt% of lactic acid Bifidobacterium Bi-07,4-6wt% of 2.664-3.996wt%
Bifidobacterium lactis HM019 and 86.008-90.672wt% oligofructose.
6. compound solid beverage according to claim 5, which is characterized in that the lactic acid bacteria compounding powder includes 3.33wt%
Lactic acid Bifidobacterium Bi-07,5wt% lactobacillus acidophilus NCFM, 3.33wt% bifidobacterium lactis HM019 and
The oligofructose of 88.34wt%.
7. compound solid beverage described in any one of -4 according to claim 1, which is characterized in that the preparation side of the taro powder
Method are as follows:
A. cutting is the glycan grain of 9-12mm after fresh glycan being removed the peel;
B. the glycan grain is air-dried into dehydration to water content and is not more than 40wt%, it is dry to obtain glycan;
C. carry out low temperature pressurizing and ageing for the glycan is dry, wherein the temperature of the curing be at 80-100 DEG C, the curing
Pressure is 101.3-202.6KP, and the dry air-cooled dehydration of progress of glycan after curing is obtained de- until water content is not more than 15wt%
Water glycan is dry;
D. the dehydration glycan dry powder is broken to fineness no more than 246um to get taro powder.
8. compound solid beverage described in any one of -4 according to claim 1, which is characterized in that the preparation side of the raspberry powder
Method are as follows:
S1: being sliced after fresh raspberry cleaning is drained, microwave drying then carried out at 65-70 DEG C, wherein drying time be
It is dry to obtain raspberry by 10-13min;
S2: the raspberry is done to the quick-frozen 2-2.5min of liquid nitrogen spraying of -180--160 DEG C of use, is then lyophilized, must be freezed again
Raspberry is dry;
S3: the freezing raspberry dry powder is broken to fineness no more than 246um to get raspberry powder.
9. compound solid beverage according to claim 8, which is characterized in that the vacuum degree of freeze-drying described in step S2 is
0.1-0.5KPa, condenser temperature are -30 DEG C, and heating temperature is 35-40 DEG C, heating time 2-3h.
10. a kind of prepare for improving the method for the compound solid beverage of intestinal flora as described in any one of claim 1-3,
Include the following steps:
(1) the synthetism rasp berry fruit powder, A Sayi fruit powder, Noni fruit powder, Cranberry powder and blueberry powder are mixed into 25-35min,
Obtain the first mixed powder;
(2) first mixed powder is compounded into powder, maltitol, wood with the raspberry powder, blackcurrant powder, strawberry powder, lactic acid bacteria
Sugar alcohol, taro powder and oligofructose mixing 1.8-2.2h are to get the compound solid beverage.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810432982.XA CN110447799A (en) | 2018-05-08 | 2018-05-08 | A kind of complex solid plant beverage and preparation method thereof for improving intestinal flora |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810432982.XA CN110447799A (en) | 2018-05-08 | 2018-05-08 | A kind of complex solid plant beverage and preparation method thereof for improving intestinal flora |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110447799A true CN110447799A (en) | 2019-11-15 |
Family
ID=68480497
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810432982.XA Pending CN110447799A (en) | 2018-05-08 | 2018-05-08 | A kind of complex solid plant beverage and preparation method thereof for improving intestinal flora |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110447799A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111296827A (en) * | 2020-02-24 | 2020-06-19 | 东莞自然衡健康科技有限公司 | Composition and application thereof |
CN112741315A (en) * | 2021-01-19 | 2021-05-04 | 然益科技(深圳)有限公司 | Fruit probiotic dietary fiber powder solid beverage and preparation method thereof |
CN112971078A (en) * | 2021-04-01 | 2021-06-18 | 橡果美健实业投资股份有限公司 | Absorbable jelly capable of conditioning intestinal flora and preparation method of absorbable jelly |
CN113974043A (en) * | 2021-10-18 | 2022-01-28 | 山东星光首创生物科技有限公司 | Prebiotics solid beverage and preparation method thereof |
CN116035150A (en) * | 2022-12-30 | 2023-05-02 | 安徽中志科技有限公司 | Selenium-enriched elderberry solid beverage |
WO2023167602A1 (en) * | 2022-03-03 | 2023-09-07 | Fortifruits Spółka Z Ograniczoną Odpowiedzialnością | The method of producing fruit or plant powder with fruit or plant extract with increased content of bioactive compounds and fruit or plant powder with fruit or plant extract with increased content of bioactive compounds |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1173979A (en) * | 1996-08-16 | 1998-02-25 | 黎军 | Production process of taro powder |
CN101675775A (en) * | 2008-09-19 | 2010-03-24 | 朱长满 | Taro chip and production method thereof |
CN106262111A (en) * | 2016-08-26 | 2017-01-04 | 浙江奇异鸟生物科技有限公司 | A kind of preparation method of Fructus Fragariae Ananssae powder |
CN106473148A (en) * | 2016-09-14 | 2017-03-08 | 吴卓蓉 | A kind of compound probiotic composition and preparation method and application |
CN106605919A (en) * | 2016-11-01 | 2017-05-03 | 西安源森生物科技有限公司 | Composition used for removing food retention and relaxing bowels of children, as well as preparation method thereof |
CN107981145A (en) * | 2017-11-28 | 2018-05-04 | 天津活力达生物科技有限公司 | A kind of probiotics solid beverage and preparation method thereof |
-
2018
- 2018-05-08 CN CN201810432982.XA patent/CN110447799A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1173979A (en) * | 1996-08-16 | 1998-02-25 | 黎军 | Production process of taro powder |
CN101675775A (en) * | 2008-09-19 | 2010-03-24 | 朱长满 | Taro chip and production method thereof |
CN106262111A (en) * | 2016-08-26 | 2017-01-04 | 浙江奇异鸟生物科技有限公司 | A kind of preparation method of Fructus Fragariae Ananssae powder |
CN106473148A (en) * | 2016-09-14 | 2017-03-08 | 吴卓蓉 | A kind of compound probiotic composition and preparation method and application |
CN106605919A (en) * | 2016-11-01 | 2017-05-03 | 西安源森生物科技有限公司 | Composition used for removing food retention and relaxing bowels of children, as well as preparation method thereof |
CN107981145A (en) * | 2017-11-28 | 2018-05-04 | 天津活力达生物科技有限公司 | A kind of probiotics solid beverage and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
张勇等: "双叉奶中合生元对改善肠道菌群功效的研究", 《中国微生态学杂志》 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111296827A (en) * | 2020-02-24 | 2020-06-19 | 东莞自然衡健康科技有限公司 | Composition and application thereof |
CN112741315A (en) * | 2021-01-19 | 2021-05-04 | 然益科技(深圳)有限公司 | Fruit probiotic dietary fiber powder solid beverage and preparation method thereof |
CN112971078A (en) * | 2021-04-01 | 2021-06-18 | 橡果美健实业投资股份有限公司 | Absorbable jelly capable of conditioning intestinal flora and preparation method of absorbable jelly |
CN113974043A (en) * | 2021-10-18 | 2022-01-28 | 山东星光首创生物科技有限公司 | Prebiotics solid beverage and preparation method thereof |
WO2023167602A1 (en) * | 2022-03-03 | 2023-09-07 | Fortifruits Spółka Z Ograniczoną Odpowiedzialnością | The method of producing fruit or plant powder with fruit or plant extract with increased content of bioactive compounds and fruit or plant powder with fruit or plant extract with increased content of bioactive compounds |
CN116035150A (en) * | 2022-12-30 | 2023-05-02 | 安徽中志科技有限公司 | Selenium-enriched elderberry solid beverage |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105146614B (en) | A kind of functional calcium fruit ferment, enzyme beverage and its production method | |
CN105167072B (en) | A kind of production method of feature matrimony vine ferment and its product | |
CN110447799A (en) | A kind of complex solid plant beverage and preparation method thereof for improving intestinal flora | |
CN104509864B (en) | A kind of have nutritional health food improving gastrointestinal function and preparation method thereof | |
CN104770816A (en) | Watermelon juice probiotic fermented beverage and preparation method thereof | |
CN109198356A (en) | A kind of solid beverage and preparation method thereof with adjusting function of intestinal canal | |
CN105249100B (en) | The production method of fermented fruits and vegetables juice and fermented glutinous rice beverage with compound functions | |
CN104970101A (en) | Probiotics troche and preparation method thereof | |
CN109619358A (en) | A kind of solid drinks and preparation method thereof based on soybean peptide albumen powder | |
CN105028646A (en) | Freeze-dried tablets and preparation method thereof | |
CN103653170A (en) | Stachyose probiotics solid beverage | |
CN117487683A (en) | Probiotic composition with effects of resisting claustration, protecting stomach, promoting digestion and removing food retention and application thereof | |
CN111066989A (en) | Compound beverage and preparation method thereof | |
CN105028638A (en) | Fruit and vegetable lactic acid bacteria tablet and preparation method thereof | |
CN109315769A (en) | It is a kind of for improving the composition and preparation method thereof of human body enteral environment | |
CN107594109A (en) | A kind of pet drinks enzyme liquid and preparation method thereof | |
CN107173656A (en) | A kind of Chinese medicine fruits and vegetables probiotics fermented beverage and preparation method thereof | |
CN105028637A (en) | Fruit puree tablet containing probiotics and preparation method for fruit puree tablet | |
CN105123949A (en) | Yoghourt tablet containing live bacteria and preparation method thereof | |
KR20040027180A (en) | Lactic Acid Bacteria-Fermenting Dairy Products Used for Preventing and Treating Obesity or Diabetes Mellitus and Manufacturing Method thereof | |
CN104886569A (en) | An active probiotic fermented drink and a preparation method thereof | |
CN105802876B (en) | A kind of composite probiotics ferment clover tender shoots powder preparation and its preparation method and application | |
CN105104529A (en) | Lactobacillus food and preparation method thereof | |
CN105123932A (en) | Fruit and vegetable probiotic tablet and preparation method thereof | |
CN105029598A (en) | Active watermelon juice fermented beverage and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191115 |
|
RJ01 | Rejection of invention patent application after publication |